Agilitas, a London-based mid-market PE firm, completed the acquisition of Frontier Medical Group, a medical device manufacturer that focuses on skin and wound care, from primary buyout specialist Kester Capital. Financial terms were not disclosed. "We are delighted to become part of the Agilitas portfolio. This transaction is in line with our global strategy as we continue to invest in strengthening our skin and wound care business in both the UK and international markets. It offers us a great opportunity as we reinforce our position as a company oriented to offering clinically and cost-effective solutions to our customers, launch further new products and open a new head office and manufacturing site later in 2021," Simon Jackson, Frontier Medical Group CEO.